Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia

Br J Haematol. 2010 Aug;150(4):480-1. doi: 10.1111/j.1365-2141.2010.08218.x. Epub 2010 Apr 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Drug Administration Schedule
  • Female
  • Humans
  • Leukemia, Large Granular Lymphocytic / drug therapy*
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic / chemically induced

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab